Position in EBS
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$83,800
+$800 QoQ
Shares Held
10,000
0.0% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#130
of 194 holders
Holding Since
Mar 2020
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in EBS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026VERUS CAPITAL PARTNERS, LLC holds $242,296 across 2 Drug Manufacturers - Specialty & Generic names. EBS ranks #2 (34.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AQST |
Aquestive Therapeutics, Inc.
|
38,100 | $158,496 | |
| 2 | EBS |
Emergent BioSolutions Inc.
This page
|
10,000 | $83,800 |
All Filings in EBS
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $83,800 | 10,000 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $83,000 | 10,000 | Shares | Sole | 2026-05-22 | |
| 2025-12-31 | $123,600 | 10,000 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $88,200 | 10,000 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $63,800 | 10,000 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $48,600 | 10,000 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $95,600 | 10,000 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $83,500 | 10,000 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $68,200 | 10,000 | Shares | Sole | 2024-08-01 | |
| 2020-03-31 | $4,628 | 80 | Shares | Sole | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||